A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
BAILEYTON, Tenn. (WJHL) — Organizations worked together to improve access to naloxone in Greene County to save lives that ...
The company has rallied from an earlier setback in obesity thanks to early progress for a drug targeting “NLRP3,” an ...
The US Food and Drug Administration (FDA) has called on its Pharmacy Compounding Advisory Committee to discuss whether a ...
BD200 demonstrated superior uptake and cellular cytotoxicity when compared to approved drugs targeting either Trop-2 or ...
U.S. President Donald Trump this week signed an executive order directing health regulators to speed reviews of psychedelic ...
ImmunityBio, Inc. (NASDAQ: IBRX) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio securities between January 19, 2026 and ...
This article explores how building structured, connected data systems is essential to unlocking reliable insights, ...
Establishing an innovative class of polyomavirus antivirals spanning BK and JC virus indications CANTON, Mass.--(BUSINESS ...
Almost four months ahead of schedule, Corcept Therapeutics' selective glucocorticoid receptor antagonist (SGRA) relacorilant has been cleared for sale in the US as a treatment for ovarian, fallopian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results